col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


59 Results       Page 1

 [1] 
American Association for Cancer Research: Cancer Research
  original article Date Title Authors   All Authors
1 [GO] 2022―Mar―08 Abstract P4-12-09: Implications of protocol modifications and treatment delays for breast cancer patient experiences during Covid-19 Tamara Hamlish, Elizabeth L Papautsky
2 [GO] 2022―Mar―08 Abstract P3-01-12: The impact of COVID-19 on diagnosis of recurrent breast cancer Serena Di Cosimo, Catherine Depretto, Rosalba Miceli, Paolo Baili, Silva Ljevar, Milena Sant, et al. (+12)
3 [GO] 2022―Mar―08 Abstract P2-11-08: Impact of COVID-19 on patients undergoing neoadjuvant therapy: A pre/post pandemic analysis and assessment of quality of care delivered Lauren Corke, Omar Hajjaj, Kaylie Willemsma, Stephen Chia, Christine Simmons
4 [GO] 2022―Mar―08 Abstract P2-10-05: The estimated impact of COVID-19 on population breast cancer screening outcomes, and options for risk-based recovery Pietro Procopio, Sabine Deij, Louiza S Velentzis, Amanda Tattam, Lara Petelin, Carolyn Nickson
5 [GO] 2022―Mar―08 Abstract P1-17-07: Consequences of stopping a 4/6 cyclin D-dependent kinase Inhibitor in metastatic breast cancer patients with clinical benefit on endocrine treatment, in the context of the COVID-19 outbreak Sophie Martin, Carole Pflumio, Philippe Trensz, Frederique Schaff-Wendling, Michal Kalish, Cathie Fischbach, et al. (+4)
6 [GO] 2022―Mar―08 Abstract P3-12-37: The impact of the COVID-19 outbreak on breast cancer stage in the Netherlands by screening status Anouk H Eijkelboom, Sabine Siesling, Linda de Munck, Carla H van Gils, Marc BI Lobbes, Vivianne CG Tjan-Heijnen, et al. (+4)
7 [GO] 2022―Mar―08 Abstract P3-12-09: Impact of the COVID-19 outbreak on the treatment strategy of Dutch breast cancer patients Anouk H Eijkelboom, Sabine Siesling, Linda de Munck, Desiree HJG van den Bongard, Willemien Menke-van der Houven van Oordt, Pieter J Westenend, et al. (+12)
8 [GO] 2022―Mar―08 Abstract P5-14-06: Predictors of adherence to oral endocrine therapy in racial and ethnic minority patients with low socioeconomic status before and during the COVID-19 pandemic Sama Rahimi, Onyebuchi Ononogbu, Anjana Mohan, Daniel Moussa, Susan Abughosh, Meghana V Trivedi
9 [GO] 2022―Mar―08 Abstract P5-14-03: National claims data analysis of breast cancer diagnosis and treatment before versus during the COVID-19 pandemic Jennifer L Caswell-Jin, Maryam N Shafaee, Lan Xiao, Mina Liu, Natasha Purington, Esther M John, et al. (+2)
10 [GO] 2022―Mar―08 Abstract P5-14-15: Examining inequities related to inpatient hospital length of stay for breast cancer patients: A retrospective study during the COVID-19 pandemic Sailaja Kamaraju, Bethany Canales, Tamiah Wright, John Charlson, Aniko Szabo, Thomas Wetzel, et al. (+2)
11 [GO] 2022―Mar―08 Abstract P5-14-01: National claims data analysis of breast cancer diagnosis and treatment before versus during the COVID-19 pandemic Jennifer L Caswell-Jin, Maryam N Shafaee, Lan Xiao, Mina Liu, Natasha Purington, Esther M John, et al. (+2)
12 [GO] 2022―Mar―08 Abstract P2-13-17: A phase III, randomized, multicenter, double-blind study to compare efficacy and safety of EG12014 (EirGenix trastuzumab) with Herceptin® as neoadjuvant treatment in combination with anthracycline/paclitaxel-based systemic therapy in patients with HER2-positive early breast cancer - a multinational phase III study conducted during the COVID-19 pandemic Barbara Grohmann-Izay, Chiun-Sheng Huang, Giorgi Dzagnidze, Nestor Llinas, Anand Misra, Denys Pominchuk, et al. (+6)
13 [GO] 2022―Mar―08 Abstract P3-04-04: Multi-institutional perspective on screening mammography and breast cancer stage at diagnosis during the COVID-19 pandemic Sarah J Stephens, Maxwell R Lloyd, Julian C Hong, Tejas Mehta, Ted A James, Rachel Blitzblau, et al. (+2)
14 [GO] 2022―Mar―08 Abstract P3-23-04: A comprehensive, multidisciplinary approach to breast cancer treatment during the COVID-19 pandemic improves time to treatment Amila Orucevic, Robin Hutson, Robert Heidel, Jillian Lloyd, Garnetta Morin-Ducote, Christine Lauro, et al. (+5)
15 [GO] 2022―Mar―08 Abstract P4-12-12: Assessing the impact of the COVID-19 pandemic on cancer treatment decision-making and care experiences Noura Alsafar, Desiree Hao, Nimira Alimohamed, Sunil Samnani, Sasha Lupichuk
16 [GO] 2022―Mar―08 Abstract P3-09-19: The utility of using genomic testing on needle core biopsies during the COVID-19 pandemic: Molecular characterization, risk stratification, neoadjuvant outcome, and future implications Hani Katerji, Huina Zhang, Xi Wang, Linda Schiffhauer, Ajay Dhakal, Alissa Huston, et al. (+3)
17 [GO] 2022―Mar―08 Abstract P3-03-19: Incidence and time to resolution of axillary adenopathy on mammography after COVID-19 vaccination Kristin Robinson, Santo Maimone, Pooja P Advani, Zhuo Li, Denise Gococo-Benore, Neda Qosja, et al. (+8)
18 [GO] 2022―Mar―08 Abstract P1-01-01: Prospective ultrasonographic surveillance study for incidence and recovery period of COVID-19 vaccination-related axillary lymphadenopathy Kumiko Kida, Hiroko Tsunoda, Risa Kasahara, Chika Tsutsumi, Akiko Numata, Yuri Takehara, et al. (+5)
19 [GO] 2022―Mar―08 Abstract P5-14-17: Declining the COVID-19 vaccination: An evaluation of why some high risk cancer patients decline vaccination Kate I Lathrop, Eva Prieto, Stefany Viveros, Salyna Riggs, Eva Balboa, Juanita Murray, et al. (+2)
20 [GO] 2022―Mar―08 Abstract P2-15-03: Neoadjuvant endocrine therapy (NET) as bridge therapy for early stage breast cancer during COVID-19: A single institution experience Julie Huang, Joshua Feinberg, Bahram Dabiri, Jordan Baum, Meredith Akerman, Anthony Pasquarella, et al. (+4)
21 [GO] 2022―Mar―08 Abstract P2-03-01: Changes in breast cancer presentation during Covid-19: Experience in an Urban Academic Center Amber Azniv Guth, Brian Diskin, Freya Schnabel, Nakisa Pourkey, Deborah Axelrod, Richard Shapiro
22 [GO] 2022―Mar―08 Abstract P5-14-20: Neoadjuvant endocrine therapy (NET) during COVID-19: Single institution survey of patients’ perspectives Julie Huang, Joshua Feinberg, Meredith Akerman, Anthony Pasquarella, Abhinav Rohatgi, Bahram Dabiri, et al. (+4)
23 [GO] 2022―Mar―08 Abstract P3-23-01: Antibody responses after SARS-CoV-2 mRNA vaccination in breast cancer patients Saranya Chumsri, Pooja P. Advani, Tanmayi S Pai, Zhou Li, Marites Acampora, Gina A Reynolds, et al. (+3)
24 [GO] 2022―Mar―08 Abstract P4-10-03: Immunogenicity of SARS-CoV-2 vaccination in subjects on active treatment for breast cancer Cory Bivona, Kevin Li, Priyanka Sharma, Jianghua He, Grace Martin, Andrew K Godwin, et al. (+19)
25 [GO] 2022―Mar―08 Abstract P3-23-02: Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer receiving CDK 4/6 inhibitors Elyssa Denault, Erika Nakajima, Vivek Naranbhai, Alejandro Balazs, Lindsey Mortensen, Elizabeth Niehoff, et al. (+11)
26 [GO] 2022―Mar―08 Abstract P3-11-02: Evaluation of the effects of anticancer treatments in cancer patients undergoing SARS-COV2 vaccination (VAX-on study: Breast cancer subgroup analysis) Agnese Fabbri, Eleonora Marrucci, Fabrizio Nelli, Marco Mazzotta, Angelo Onorato, Primi Francesca, et al. (+7)
27 [GO] 2022―Mar―08 Abstract P4-10-06: Best quality care from a distance (BQual-D): Maintaining high quality care for hormone receptor positive (HR+) metastatic breast cancer (MBC) during the COVID pandemic, description of the program and provider satisfaction Gretchen Kimmick, Smrithi Davakaran, Heather Moore, Cynthia Rose, Pamela Gentry, Michael Willis, et al. (+6)
28 [GO] 2022―Mar―08 Abstract P4-12-13: Psychosocial aspects in relation to clinical status of breast cancer patients after prolonged COVID pandemic in south India: A observational survey study Chandralekha Krishnan
29 [GO] 2022―Mar―08 Abstract P5-14-04: Changes in management of TNBC during the COVID19 pandemic of 2020 Dave Smart, Wendy L Allen, Raymond H Henderson, Susanne Munksted, Peter Riccelli
30 [GO] 2022―Mar―08 Abstract P3-17-06: Telephone triaging during the 1st wave of the COVID 19 Pandemic: Outcomes and proposed pathway for managing patients referred for breast pain Urvashi Jain, Robyn Coombe, Georgina Bitsakou, Ashutosh Kothari
31 [GO] 2021―Nov―10 Longitudinal SARS-CoV-2 mRNA vaccine-induced humoral immune responses in cancer patients Jane C Figueiredo, Noah M Merin, Omid Hamid, So Yung Choi, Tucker Lemos, Wendy Cozen, et al. (+27)
32 [GO] 2021―Jul―01 Abstract 703: An inflammatory leptomeningeal signature in cancer patients with neurologic manifestations of COVID-19 Jessica A. Wilcox, Jan Remsik, N. Esther Babady, Tracy A. McMillen, Behroze A. Vachha, Neil A. Halpern, et al. (+6)
33 [GO] 2021―Jul―01 Abstract 710: Androgen-deprivation therapy boosts MX1 expression, a silent effector against COVID-19 Juan Antonio Bizzotto, Pablo Sanchis, Sofia Lage-Vickers, Rosario Lavignolle, Agustina Sabater, Mercedes Abbate, et al. (+9)
34 [GO] 2021―Jul―01 Abstract 714: From cancer to COVID-19- development of a dendritic cell-targeted nano-vaccine for prevention and therapy of COVID-19 Daniella Vaskovich-Koubi, Ron Kleiner, Yulia Liubomirski, Eilam Yeini, Galia Tiram, Sabina Pozzi, et al. (+3)
35 [GO] 2021―Jul―01 Abstract 704: Sex and age differences in telomere length and susceptibility to COVID-19 Manar Ahmed Kamal, Kareem Reda Alamiry, Mahmoud Zaki
36 [GO] 2021―Jul―01 Abstract 711: Repurposing 2nd generation androgen receptor antagonist Proxalutamide to treat COVID-19 Liandong Ma, Youzhi Tong, Qiang Guo, Yifeng Zhou, Qianxiang Zhou, Honghua Yan
37 [GO] 2021―Jul―01 Abstract 709: Estrogen and androgen receptor inhibitors: Unexpected allies in the fight against COVID-19 Sara Bravaccini, Eugenio Fonzi, Michela Tebaldi, Davide Angeli, Giovanni Martinelli, Fabio Nicolini, et al. (+2)
38 [GO] 2021―Jul―01 Abstract 700: CellSig: A data-driven model of cytokine activity identifies therapeutic targets for severe COVID-19 and cancer immunotherapy-induced colitis Peng Jiang, Yu Zhang, Beibei Ru, Eytan Ruppin, Kai Wucherpfennig
39 [GO] 2021―Jul―01 Abstract 722: The hallmark of COVID-19 cancer disparities: Cellular sequelae Eva McGhee, Mengtao LI, Yi-Ling Lin, Nefertari Carr, Chinelo Njubigbo, Rohun Sadeghi, et al. (+6)
40 [GO] 2021―Jul―01 Abstract LB076: Association between regional COVID-19 hospitalizations and treatment delays amongst confirmed cancer patients in England, UK Louis Fox, Ajay Aggarwal, Richard Sullivan, Kate Haire, Arnie Purushotham, James Spicer, et al. (+4)
41 [GO] 2021―Jul―01 Abstract LB074: Chymostatin, a cathepsin L inhibitor, inhibits lung cancer cell proliferation and COVID-19 Mpro in vitro Nagendra Sastry Yarla, Gopal Pathuri, Simon Terzyan, Yuting Zhang, Anil Singh, Marcus T. Scotti, et al. (+2)
42 [GO] 2021―Jul―01 Abstract CT201: Early report of a phase I/II study of human placental hematopoietic stem cell derived natural killer cells (CYNK-001) for the treatment of adults with COVID-19 (NCT04365101) Corey Casper, Leonid Groysman, Vinay Malhotra, Eric Whitman, Stacy Herb, Erica Rave, et al. (+17)
43 [GO] 2021―Jul―01 Abstract LB073: The growth inhibitory effect of paclitaxel on gefitinib-resistant non-small cell lung cancer (NSCLC) cells during the COVID-19 pandemic Md Mohiuddin, Hideharu Kimura, Takashi Sone, Satoshi Watanabe, Hiroki Matsuoka, Keigo Saeki, et al. (+3)
44 [GO] 2021―Jul―01 Abstract 716: Telehealth use among multiple myeloma patients during the COVID-19 pandemic Nathan W. Sweeney, Scott R. Goldsmith, Jennifer M. Ahlstrom
45 [GO] 2021―Jul―01 Abstract 719: The emergence of the COVID-19 pandemic and its impact on a novel cancer care delivery model at Federally Qualified Health Centers Nicolas Francone, Will Dunne, Jonathan Alhalel, Sankirtana Danner, Nihmotallahi Adebayo, T Madorsky, et al. (+6)
46 [GO] 2021―Jul―01 Abstract 717: Rapid transformation of TTFields care-delivery during COVID-19 pandemic to optimize treatment of patients with glioblastoma (GBM) Peggy M. Frongillo, Melissa Shackelford, Lindsay Rain
47 [GO] 2021―Jul―01 Abstract 721: Early death in acute lymphoblastic leukemia during COVID-19 pandemic: A single institution cohort study Daniel J. Enriquez-Vera, Ali Al-kassab-Cordova, Lizbeth Lachira-Yparraguirre, Gustavo Sandival-Ampuero, Bryan Valcarcel, Cesar Samanez, et al. (+5)
48 [GO] 2021―Jul―01 Abstract 1162: Monitoring COVID-19 RNA methyltransferases activities for developing therapeutic drugs Said A. Goueli, Kevin Hsiao
49 [GO] 2021―Jul―01 Abstract 715: Flow cytometry analysis of immune response to COVID-19 vaccine candidates using an in vitro stimulation model Xiaoshan Shi, Scott J. Bornheimer, Suraj Saksena, Stephanie Widmann, Aaron Tyznik
50 [GO] 2021―Jul―01 Abstract 712: Anticancer natural compounds as potential inhibitors of novel coronavirus (COVID19) main protease: An in-silico study Amaresh Mishra, Yamini Pathak, Gourav Choudhir, Anuj Kumar, Surabhi Kirti Mishra, Vishwas Tripathi
51 [GO] 2021―Jul―01 Abstract 706: Rapid detection of SARS-CoV-2 antigen and antibody seroconversion in clinical specimens using a novel Surface Programmable Activation Receptor (SPAR) modified T cell diagnostic method Aaron K. LeFebvre, Melissa Frenchmeyer, Kyle M. McQuaid, MRussell Williams, Charles M. McBrairty, Joseph D. Kittle
52 [GO] 2021―Jul―01 Abstract 713: Inhibition of pseudo SARS-CoV-2 binding activity of a anti-cancer polypharmacological agent analogs Rao V. Papineni, Amitava Adhikary, Ritesh Tandon, Dipanwita Mitra
53 [GO] 2021―Jul―01 Abstract 707: Detection of SARS-CoV-2 co-infections with seasonal respiratory viruses using a multiplexed amplicon NGS panel Lucie S. Lee, Rounak Feigelman, David Debruyne, Julia Spencer, Chenyu Li, Zhitong Liu, Guoying Liu
54 [GO] 2021―Jul―01 Abstract 701: The acute phase response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection as quantified by the OnCovid Inflammatory Score Gino M. Dettorre, Saoirse Dolly, Angela Loizidou, John Chester, Amanda Jackson, Uma Mukherjee, et al. (+44)
55 [GO] 2021―Jul―01 Abstract 705: SARS-CoV-2 infection of the human heart governs intracardiac innate immune response Anthony W. Ashton, Liang Zhang, Yan Liang, Prajan Divakar, Carolos Cordon-Cardo, Richard G. Pestell
56 [GO] 2021―Jul―01 Abstract LB075: Development of SARS-CoV-2 neutralizing protein by ACE2 receptor engineering for severe infection and patients with underlying diseases Byoung S. Kwon, Seunghyun Lee, Jin-Kyung Choi, Bora Hwang, Sun-Woo Im, Yun-Sook Lim, et al. (+3)
57 [GO] 2021―Jul―01 Abstract LB072: SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus Zhiqiang Qin, Jungang Chen, Lu Dai, Lindsey Barrett, Steven Post
58 [GO] 2021―Jul―01 Abstract 702: Single-cell expression landscape of SARS-CoV-2 receptor ACE2 and host proteases in human lung adenocarcinoma Guangchun Han, Ansam Sinjab, Kieko Hara, Warapen Treekitkarnmongkol, Patrick Brennan, Kyle Chang, et al. (+25)
59 [GO] 2020―Dec―22 Is COVID-19 - induced platelet activation a cause of concern for cancer patients? Lenard M. Lichtenberger, K. Vinod Vijayan
 [1] 

59 Results       Page 1


[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.008 sec